Contact Us
Subscribe
e-Edition

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

16°

Site search

Home
News
- Local News
Sports
Obituaries
e-Edition
Classifieds
Explore the Sheyenne
Archives
Best of 2025
2026 Calendar

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

BioMarin Pharmaceutical Inc. - Common Stock (NQ:BMRN)

53.83 -0.48 (-0.89%)

Streaming Delayed Price Updated: 3:16 PM EST, Dec 4, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about BioMarin Pharmaceutical Inc. - Common Stock

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

ALERT: BioMarin Pharmaceutical Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – BMRN

October 30, 2021

From Robbins Geller Rudman & Dowd LLP

Via Business Wire

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of NNOX, BMRN and RECAF

October 29, 2021

NEW YORK, NY / ACCESSWIRE / October 29, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to...

From The Klein Law Firm

Via AccessWire

Topics Fraud Lawsuit

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of SAM, BMRN and AMRN

October 29, 2021

NEW YORK, NY / ACCESSWIRE / October 29, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly-traded companies....

From The Gross Law Firm

Via AccessWire

Topics Intellectual Property

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of HYZN, INNV and BMRN

October 28, 2021

NEW YORK, NY / ACCESSWIRE / October 28, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies....

From The Gross Law Firm

Via AccessWire

Topics Lawsuit

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of HYZN, BMRN and AMRN

October 28, 2021

From The Gross Law Firm

Via AccessWire

Topics Intellectual Property

BioMarin's Q3 Net Income Hit By Lower Product Sales ↗

October 28, 2021

BioMarin Pharmaceutical Inc (NASDAQ: BMRN) reported a 14% Y/Y decrease in Q3 revenue to $408.7 million, missing the consensus estimate of $435.32 million. The decline...

Via Benzinga

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ZEV, BMRN and AMRN

October 28, 2021

AMRN The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss,...

From The Klein Law Firm

Via AccessWire

Topics Fraud Intellectual Property Lawsuit

BioMarin Pharmaceutical inc (BMRN) Q3 2021 Earnings Call Transcript ↗

October 28, 2021

BMRN earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

BMRN ALERT: Robbins Geller Rudman & Dowd LLP Announces that BioMarin Pharmaceutical Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

October 27, 2021

SAN DIEGO, CA / ACCESSWIRE / October 27, 2021 / The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) securities between...

From Robbins Geller Rudman & Dowd LLP

Via AccessWire

Topics Lawsuit

BIOMARIN ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against BioMarin Pharmaceuticals and Encourages Investors to Contact the Firm

October 27, 2021

From Bragar Eagel & Squire, P.C.

Via Business Wire

Lawsuits Filed Against SAM, BMRN and RECAF - Jakubowitz Law Pursues Shareholders Claims

October 27, 2021

NEW YORK, NY / ACCESSWIRE / October 27, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies...

From Jakubowitz Law

Via AccessWire

Topics Fraud Lawsuit

Biomarin Pharmaceutical: Q3 Earnings Insights ↗

October 27, 2021

Biomarin Pharmaceutical (NASDAQ:BMRN) reported its Q3 earnings results on Wednesday, October 27, 2021 at 04:05 PM. Here's what investors need to know about the announcement....

Via Benzinga

SHAREHOLDER ALERT: INNV HEPS BMRN: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

October 27, 2021

NEW YORK, NY / ACCESSWIRE / October 27, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a...

From The Law Offices of Vincent Wong

Via AccessWire

Topics Fraud Lawsuit

CLASS ACTION UPDATE for EAR, NNOX and BMRN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

October 27, 2021

NEW YORK, NY / ACCESSWIRE / October 27, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies....

From Levi & Korsinsky, LLP

Via AccessWire

Topics Lawsuit

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against BioMarin Pharmaceutical Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

October 27, 2021

From The Schall Law Firm

Via Business Wire

LAWSUITS FILED AGAINST EAR, BMRN and RECAF -Jakubowitz Law Pursues Shareholders Claims

October 26, 2021

NEW YORK, NY / ACCESSWIRE / October 26, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies...

From Jakubowitz Law

Via AccessWire

Topics Fraud Lawsuit

SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against BioMarin Pharmaceutical Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

October 26, 2021

From The Schall Law Firm

Via Business Wire

CLASS ACTION UPDATE for HYRE, WDH and BMRN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

October 26, 2021

NEW YORK, NY / ACCESSWIRE / October 26, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies....

From Levi & Korsinsky, LLP

Via AccessWire

Topics Initial Public Offering Lawsuit

BMRN ALERT: BioMarin Pharmaceutical Inc. Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit

October 26, 2021

From Robbins Geller Rudman & Dowd LLP

Via Business Wire

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of KPLT, BMRN and AMRN

October 26, 2021

NEW YORK, NY / ACCESSWIRE / October 26, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to...

From The Klein Law Firm

Via AccessWire

Topics Fraud Intellectual Property

SHAREHOLDER ALERT: HEPS BMRN AMRN: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

October 26, 2021

NEW YORK, NY / ACCESSWIRE / October 26, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a...

From The Law Offices of Vincent Wong

Via AccessWire

Topics Fraud Intellectual Property Lawsuit

Lawsuits Filed Against HYZN, NNOX and BMRN - Jakubowitz Law Pursues Shareholders Claims

October 25, 2021

NEW YORK, NY / ACCESSWIRE / October 25, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies...

From Jakubowitz Law

Via AccessWire

Topics Fraud Lawsuit

EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages BioMarin Pharmaceutical Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – BMRN

October 25, 2021

From Rosen Law Firm

Via Business Wire

The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More ↗

October 24, 2021

Biotech stocks posted gains for the second week running, supported by multiple catalysts that included a good start to the big pharma reporting season and broader market strength...

Via Benzinga

Barron's Latest Picks And Pans: Amazon, Apple, Chevron, Citigroup, Dell And More ↗

October 16, 2021

This weekend's Barron's cover story features the latest results of the annual Barron's Big Money Poll. Other featured articles discuss which companies may benefit...

Via Benzinga

NASDAQ:BMRN Investor Notice: Investigation over Possible Securities Laws Violations by BioMarin Pharmaceutical Inc. ↗

September 22, 2021

San Diego, CA -- (SBWIRE) -- 09/22/2021 -- BioMarin Pharmaceutical Inc. is under investigation over potential securities laws violations in connection with certain financial statements.

Via SBWire

Stifel Upgrades This Pharma Stock On Prospective FDA Approval For Dwarfism Drug ↗

September 09, 2021

Stifel

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2021 ↗

September 09, 2021

Upgrades According to Benchmark, the prior rating for TopBuild Corp (NYSE:

Via Benzinga

Price To Earnings Ratio Insights For Biomarin Pharmaceutical ↗

September 07, 2021

In the current market session, Biomarin Pharmaceutical Inc. (NASDAQ:BMRN) is trading at $80.65, after a 5.06% drop. However, over the past month, the stock spiked by...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

September 07, 2021

Gainers Pliant Therapeutics (NASDAQ:PLRX) shares rose 25.62% to $24.27 during Tuesday's pre-market session. The market value of their outstanding shares is at $872.2...

Via Benzinga

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Entertainment
Local Events
Sports
Obituaries
Multimedia
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Email Alerts
Search
Weather

times-online.com
146 Third St. N.E.
Valley City, ND 58072
Phone: 701-845-0463
Email: vctr@times-online.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

BioMarin Pharmaceutical Inc. - Common Stock (NQ:BMRN)

All News about BioMarin Pharmaceutical Inc. - Common Stock

Sections

Services

Follow Us